GT BIOPHARMA, INC. Liabilities, Noncurrent
GT BIOPHARMA, INC. (GTBP) had Liabilities, Noncurrent of $0 as of 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2018-03-01
- 2017-12-31: Liabilities, Noncurrent $0.00.
- 2016-12-31: Liabilities, Noncurrent $0.00.
- 2016-09-30: Liabilities, Noncurrent $400.00K.
- 2016-06-30: Liabilities, Noncurrent $528.00K.
| Period end | Liabilities, Noncurrent |
|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-01 |
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 |
| 2016-09-30 | $400.00K 10-Q/A · filed 2018-02-28 |
| 2016-06-30 | $528.00K 10-Q/A · filed 2018-02-28 |
| 2016-03-31 | $553.00K 10-Q/A · filed 2018-02-28 |
| 2015-12-31 | $714.00K 10-K/A · filed 2018-02-28 |
| 2015-09-30 | $2.29M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $1.45M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $849.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $634.00K 10-K/A · filed 2018-02-28 |
| 2014-09-30 | $306.00K 10-Q · filed 2015-01-08 |
| 2014-06-30 | $156.00K 10-Q · filed 2015-01-08 |
| 2014-03-31 | $128.00K 10-Q · filed 2015-01-08 |
| 2013-12-31 | $97.00K 10-K · filed 2015-03-31 |
| 2012-12-31 | $0.00 10-K · filed 2015-01-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |